Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GLP-1 therapies like Semaglutide and Tirzepatide are FDA-approved for managing weight loss and supporting diabetes care
00:06:56 Vickie Danaher But keep in mind that there arent any published head-to-head trials for these two medications in obesity
For instance, in clinical trials, Retatrutide achieved up to a 24.2% reduction in body weight over 48 weeks, whereas Tirzepatide users saw an average weight loss of 19.5% and 20.9% after 72 weeks of treatment (10-mg and 15-mg dose, respectively)
however, given that TMAO levels are also greatly influenced by diet-microbiota interactions that are subjected to great variability, the link between TMAO and some human cancers cannot be easily defined (Oellgaard et al., 2017)
Why Choose GLP-1 injections for Weight Loss
La Liraglutida tiene el potencial de ayudar a estas personas a lograr una prdida de peso sostenida de manera clnicamente significativa, misma que les ayudar a aminorar la carga que representa el exceso de peso y las comorbilidades relacionadas a ste, coment Morten Vaupel, vicepresidente y director general de Novo Nordisk Mxico
